Structural Characterization of the Tetrameric form of the Major Cat Allergen Fel d 1

Journal of Molecular Biology

Volumn 370, Issue 4, 2007, Pages 714-727

  Kaiser, Liselotte ^a   Velickovic, Tanja Cirkovic ^a   Badia Martinez, Daniel ^a   Adedoyin, Justus ^a   Thunberg, Sarah ^a   Hallén, Dan ^b   Berndt, Kurt ^c   Grönlund, Hans ^a   Gafvelin, Guro ^a   van Hage, Marianne ^a   Achour, Adnane ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Electrum   (Sweden)

^c Novum   (Sweden)

Author keywords

calcium; cat allergen; crystal structure; Fel d 1; tetramer

Indexed keywords

ALLERGEN; CALCIUM ION; FELIS DOMESTICUS ALLERGEN 1; GLYCOPROTEIN; PHOSPHOLIPASE A2; TETRAMER; UNCLASSIFIED DRUG; UTEROGLOBIN; WATER;

ALLERGY; ARTICLE; BINDING SITE; CALCIUM BINDING; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIMERIZATION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STABILITY; PROTEIN STRUCTURE; STRUCTURAL HOMOLOGY; STRUCTURE ANALYSIS;

FELIS CATUS;

EID: 34249943865     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.04.074     Document Type: Article

References (59)

1. Freidhoff L.R., Meyers D.A., and Marsh D.G. A genetic-epidemiologic study of human immune responsiveness to allergens in an industrial population. II. The associations among skin sensitivity, total serum IgE, age, sex, and the reporting of allergies in a stratified random sample. J. Allergy Clin. Immunol. 73 (1984) 490-499
2. Johansson S.G., Nopp A., Florvaag E., Lundahl J., Soderstrom T., Guttormsen A.B., et al. High prevalence of IgE antibodies among blood donors in Sweden and Norway. Allergy 60 (2005) 1312-1315
3. Roost H.P., Kunzli N., Schindler C., Jarvis D., Chinn S., Perruchoud A.P., et al. Role of current and childhood exposure to cat and atopic sensitization. European Community Respiratory Health Survey. J. Allergy Clin. Immunol. 104 (1999) 941-947
4. Ohman J.L., Lowell F.C., and Bloch K.J. Allergens of mammalian origin. III. Properties of a major feline allergen. J. Immunol. 113 (1974) 1668-1677
5. van Ree R., van Leeuwen W.A., Bulder I., Bond J., and Aalberse R.C. Purified natural and recombinant Fel d 1 and cat albumin in in vitro diagnostics for cat allergy. J. Allergy Clin. Immunol. 104 (1999) 1223-1230
6. Kristensen A.K., Schou C., and Roepstorff P. Determination of isoforms, N-linked glycan structure and disulfide bond linkages of the major cat allergen Fel d1 by a mass spectrometric approach. Biol. Chem. 378 (1997) 899-908
7. Duffort O.A., Carreira J., Nitti G., Polo F., and Lombardero M. Studies on the biochemical structure of the major cat allergen Felis domesticus I. Mol. Immunol. 28 (1991) 301-309
8. Bond J.F., Brauer A.W., Segal D.B., Nault A.K., Rogers B.L., and Kuo M.C. Native and recombinant Fel dI as probes into the relationship of allergen structure to human IgE immunoreactivity. Mol. Immunol. 30 (1993) 1529-1541
9. Keating K.M., Segal D.B., Craig S.J., Nault A.K., Semensi V., Wasserman A.S., et al. Enhanced immunoreactivity and preferential heterodimer formation of reassociated Fel d I recombinant chains. Mol. Immunol. 32 (1995) 287-293
10. Slunt J.B., Rogers B.L., and Chapman M.D. IgE antibodies to recombinant forms of Fel d I: dichotomy between fluid-phase and solid-phase binding studies. J. Allergy Clin. Immunol. 95 (1995) 1221-1228
11. Vailes L.D., Sun A.W., Ichikawa K., Wu Z., Sulahian T.H., Chapman M.D., and Guyre P.M. High-level expression of immunoreactive recombinant cat allergen (fel d 1): targeting to antigen-presenting cells. J. Allergy Clin. Immunol. 110 (2002) 757-762
12. Seppälä U., Hägglund P., Wurtzen P.A., Ipsen H., Thorsted P., Lenhard T., et al. Molecular characterization of major cat allergen Fel d 1: expression of heterodimer by use of a baculovirus expression system. J. Biol. Chem. 280 (2005) 3208-3216
13. Grönlund H., Bergman T., Sandström K., Alvelius G., Reininger R., Verdino P., et al. Formation of disulfide-bonds and homodimers of the major cat allergen Fel d 1 equivalent to the natural allergen by expression in Escherichia coli. J. Biol. Chem. 278 (2003) 40144-40151
14. Kaiser L., Grönlund H., Sandalova T., Ljunggren H.-G., van Hage-Hamsten M., Achour A., and Schneider G. The crystal structure of the major cat allergen Fel d 1, a member of the secretoglobin family. J. Biol. Chem. 278 (2003) 37730-37735
15. Kaiser L., Grönlund H., Sandalova T., Ljunggren H.G., Schneider G., van Hage-Hamsten M., and Achour A. Production, crystallization and preliminary crystallographic study of the major cat allergen Fel d 1. Acta Crystallog. sect. D 59 (2003) 1103-1105
16. Klug J., Beier H.M., Bernard A., Chilton B.S., Fleming T.P., Lehrer R.I., et al. Uteroglobin/Clara cell 10-kDa family of proteins: nomenclature committee report. Ann. N Y Acad. Sci. 923 (2000) 348-354
17. Emes R.D., Riley M.C., Laukaitis C.M., Goodstadt L., Karn R.C., and Ponting C.P. Comparative evolutionary genomics of androgen-binding protein genes. Genome Res. 14 (2004) 1516-1529
18. Mukherjee A.B., Kundu G.C., Mantile-Selvaggi G., Yuan C.J., Mandal A.K., Chattopadhyay S., et al. Uteroglobin: a novel cytokine?. Cell Mol. Life Sci. 55 (1999) 771-787
19. Peri A., Cordella-Miele E., Miele L., and Mukherjee A.B. Tissue-specific expression of the gene coding for human Clara cell 10-kD protein, a phospholipase A2-inhibitory protein. J. Clin. Invest. 92 (1993) 2099-2109
20. Pilon A.L. Rationale for the development of recombinant human CC10 as a therapeutic for inflammatory and fibrotic disease. Ann. N Y Acad. Sci. 923 (2000) 280-299
21. Benson M., Jansson L., Adner M., Luts A., Uddman R., and Cardell L.O. Gene profiling reveals decreased expression of uteroglobin and other anti-inflammatory genes in nasal fluid cells from patients with intermittent allergic rhinitis. Clin. Exp. Allergy 35 (2005) 473-478
22. Doull I.J., Lawrence S., Watson M., Begishvili T., Beasley R.W., Lampe F., et al. Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 153 (1996) 1280-1284
23. Härd T., Barnes H.J., Larsson C., Gustafsson J.Å., and Lund J. Solution structure of a mammalian PCB-binding protein in complex with a PCB. Nature Struct. Biol. 2 (1995) 983-989
24. Umland T.C., Swaminathan S., Singh G., Warty V., Furey W., Pletcher J., and Sax M. Structure of a human Clara cell phospholipid-binding protein-ligand complex at 1.9 Å resolution. Nature Struct. Biol. 1 (1994) 538-545
25. Charpin C., Mata P., Charpin D., Lavaut M.N., Allasia C., and Vervloet D. Fel d I allergen distribution in cat fur and skin. J. Allergy Clin. Immunol. 88 (1991) 77-82
26. Miele L., Cordella-Miele E., Mantile G., Peri A., and Mukherjee A.B. Uteroglobin and uteroglobin-like proteins: the uteroglobin family of proteins. J. Endocrinol. Invest. 17 (1994) 679-692
27. Zielonka T.M., Charpin D., Berbis P., Luciani P., Casanova D., and Vervloet D. Effects of castration and testosterone on Fel dI production by sebaceous glands of male cats: I-Immunological assessment. Clin. Exp. Allergy 24 (1994) 1169-1173
28. Levin S.W., Butler J.D., Schumacher U.K., Wightman P.D., and Mukherjee A.B. Uteroglobin inhibits phospholipase A2 activity. Life Sci. 38 (1986) 1813-1819
29. Chowdhury B., Mantile-Selvaggi G., Kundu G.C., Miele L., Cordella-Miele E., Zhang Z., and Mukherjee A.B. Amino acid residues in alpha-helix-3 of human uteroglobin are critical for its phospholipase A2 inhibitory activity. Ann. N Y Acad. Sci. 923 (2000) 307-311
30. Miele L., Cordella-Miele E., Facchiano A., and Mukherjee A.B. Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I. Nature 335 (1988) 726-730
31. Chowdhury B., Mantile-Selvaggi G., Miele L., Cordella-Miele E., Zhang Z., and Mukherjee A.B. Lys43 and Asp46 in alpha-helix 3 of uteroglobin are essential for its phospholipase A2 inhibitory activity. Biochem. Biophys. Res. Commun. 295 (2002) 877-883
32. Dennis E.A. Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 269 (1994) 13057-13060
33. Andersson O., Nordlund-Moller L., Barnes H.J., and Lund J. Heterologous expression of human uteroglobin/polychlorinated biphenyl-binding protein. Determination of ligand binding parameters and mechanism of phospholipase A2 inhibition in vitro. J. Biol. Chem. 269 (1994) 19081-19087
34. Barnes H.J., Nordlund-Moller L., Nord M., Gustafsson J., Lund J., and Gillner M. Structural basis for calcium binding by uteroglobins. J. Mol. Biol. 256 (1996) 392-404
35. Nord M., Gustafsson J.A., and Lund J. Calcium-dependent binding of uteroglobin (PCB-BP/CCSP) to negatively charged phospholipid liposomes. FEBS Letters 374 (1995) 403-406
36. Dandeu J.P., Rabillon M., Beltrand M.J., Lux M., and Duval R. Immobilized metal ion affinity chromatography for the purification of Fel d I, a cat major allergen, from a house-dust extract. J. Chromatog. 512 (1990) 177-188
37. Kaiser L., Gronlund H., van Hage-Hamsten M., and Achour A. Crystallization and preliminary crystallographic data of a Fel d 1 (1 + 2) construct corresponding to the major allergen from cat. Acta Crystallog. sect. F 61 (2005) 232-234
38. Leslie A.G. Integration of macromolecular diffraction data. Acta Crystallog. sect. D 55 (1999) 1696-1702
39. CCP4. The CCP4 suite: programs for protein crystallography. Acta Crystallog. sect. D 50 (1994) 760-763
40. Vagin A.A., and Isupov M.N. Spherically averaged phased translation function and its application to the search for molecules and fragments in electron-density maps. Acta Crystallog. sect. D 57 (2001) 1451-1456
41. Jones T.A., Zou J.Y., Cowan S.W., and Kjeldgaard. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A 47 (1991) 110-119
42. Winn M.D., Isupov M.N., and Murshudov G.N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallog. sect. D 57 (2001) 122-133
43. Laskowski R.A., MacArthur M.W., Moss D.S., and Thornton J.M. PROCHECK: a program to check the stereochemical quality of pprotein structures. J. Appl. Crystallog. 26 (1993) 283-291
44. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18 (1997) 2714-2723
45. Eriksson T.L., Gafvelin G., Elfman L.H., Johansson C., Van Hage-Hamsten M., and Olsson S. T cell responses to recombinant isoforms, synthetic peptides and a mutant variant of Lep d 2, a major allergen from the dust mite Lepidoglyphus destructor. Clin. Exp. Allergy 31 (2001) 1881-1890
46. Svahn A., Linde A., Thorstensson R., Karlen K., Andersson L., and Gaines H. Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus. J. Immunol. Methods 277 (2003) 17-25
47. Saarne T., Kaiser L., Gronlund H., Rasool O., Gafvelin G., and van Hage-Hamsten M. Rational design of hypoallergens applied to the major cat allergen Fel d 1. Clin. Exp. Allergy 35 (2005) 657-663
48. Trivedi B., Valerio C., and Slater J.E. Endotoxin content of standardized allergen vaccines. J. Allergy Clin. Immunol. 111 (2003) 777-783
49. Aalberse R.C. Structural biology of allergens. J. Allergy Clin. Immunol. 106 (2000) 228-238
50. Morgenstern J.P., Griffith I.J., Brauer A.W., Rogers B.L., Bond J.F., Chapman M.D., and Kuo M.C. Amino acid sequence of Fel dI, the major allergen of the domestic cat: protein sequence analysis and cDNA cloning. Proc. Natl Acad. Sci. USA 88 (1991) 9690-9694
51. Jones S., and Thornton J.M. Protein-protein interactions: a review of protein dimer structures. Prog. Biophys. Mol. Biol. 63 (1995) 31-65
52. Lo Conte L., Chothia C., and Janin J. The atomic structure of protein-protein recognition sites. J. Mol. Biol. 285 (1999) 2177-2198
53. Beato M. Binding of steroids to uteroglobin. J. Steroid Biochem. 7 (1976) 327-334
54. Gillner M., Lund J., Cambillau C., Alexandersson M., Hurtig U., Bergman A., et al. The binding of methylsulfonyl-polychloro-biphenyls to uteroglobin. J. Steroid Biochem. 31 (1988) 27-33
55. Lopez de Haro M.S., Perez Martinez M., Garcia C., and Nieto A. Binding of retinoids to uteroglobin. FEBS Letters 349 (1994) 249-251
56. Bally R., and Delettre J. Structure and refinement of the oxidized P21 form of uteroglobin at 1.64 Å resolution. J. Mol. Biol. 206 (1989) 153-170
57. Pattabiraman N., Matthews J.H., Ward K.B., Mantile-Selvaggi G., Miele L., and Mukherjee A.B. Crystal structure analysis of recombinant human uteroglobin and molecular modeling of ligand binding. Ann. N Y Acad. Sci. 923 (2000) 113-127
58. Morize I., Surcouf E., Vaney M.C., Epelboin Y., Buehner M., Fridlansky F., et al. Refinement of the C222(1) crystal form of oxidized uteroglobin at 1.34 Å resolution. J. Mol. Biol. 194 (1987) 725-739
59. Umland T.C., Swaminathan S., Furey W., Singh G., Pletcher J., and Sax M. Refined structure of rat Clara cell 17 kDa protein at 3.0 Å resolution. J. Mol. Biol. 224 (1992) 441-448